You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (6) |
Back to Search
Stereolithographic (SLA) 3D Printing of Oral Modified-Release Dosage Forms
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-C-024-Tuesday
- By: ROBLES MARTINEZ, Pamela (UCL School of Pharmacy, Pharmaceutics, London, United Kingdom)
- Co-author(s): Pamela Robles Martinez: Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
Alvaro Goyanes Goyanes: FabRx Ltd., Kent, United Kingdom
Jie Wang: Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
Simon Gaisford: FabRx Ltd., Kent, United Kingdom;Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
Abdul Basit: FabRx Ltd., Kent, United Kingdom;Pharmaceutics, UCL School of Pharmacy, London, United Kingdom - Abstract:
Backgrounds
3D printing (3DP) is a popular technology that provides the ability to fabricate structures of precise geometries. Stereolithography (SLA) is a type of 3DP technology in which the production of the object is based on the solidification of a liquid resin by photopolymerization.Aims
Manufacture drug loaded tablets by SLA with two model.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026